Streetbeat News

Analyst Ratings

PI

Susquehanna analyst Christopher Rolland maintains a Positive rating on Impinj (NASDAQ:PI) and raises the price target from $115 to $130.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 3:09 pm

NET

Susquehanna analyst Aaron Samuels maintains a Neutral rating on Cloudflare (NYSE:NET) and raises the price target from $75 to $115.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 3:08 pm

LITE

Susquehanna analyst Christopher Rolland maintains a Positive rating on Lumentum Holdings (NASDAQ:LITE) but lowers the price target from $65 to $60.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 3:06 pm

CYBR

Susquehanna analyst Shyam Patil maintains a Positive rating on CyberArk Software (NASDAQ:CYBR) and raises the price target from $255 to $310.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 3:03 pm

BKNG

Financial analysis reveals a bearish sentiment among traders towards Booking Holdings (NASDAQ:BKNG), with a significant portion of options trades indicating expectations for the stock's price to fluctuate between $2420.0 and $4800.0. Despite this, professional analysts have set an average price target of $4022.0, with ratings ranging from Neutral to Buy. Booking Holdings, a leading online travel agency, is currently experiencing a slight decrease in stock price, with an upcoming earnings announcement expected to potentially influence its market standing.

Portfolio Pulse from Benzinga Insights

February 09, 2024 | 3:01 pm

ARM

ARM Holdings (NASDAQ:ARM) has seen significant options activity, indicating a split sentiment among big-money traders, with 52% bullish and 47% bearish. The options trades suggest a price window of $90.0 to $120.0. ARM's current trading volume is 8,725,553, with a price drop of -7.35%, and an RSI indicating potential overbought status. Analysts have set an average price target of $100.0, with ratings ranging from Overweight to Buy. The unusual options activity could signal insider knowledge of upcoming developments.

Portfolio Pulse from Benzinga Insights

February 09, 2024 | 3:01 pm

TROW

Six analysts have recently updated their ratings on T. Rowe Price Gr (NASDAQ:TROW), showing a mix of views with 2 indifferent, 3 somewhat bearish, and 1 bearish ratings. The average 12-month price target for TROW has been raised to $101.83 from $95.80, indicating a positive sentiment shift. Analysts from firms like Wells Fargo, Morgan Stanley, UBS, TD Cowen, and Deutsche Bank have adjusted their price targets, reflecting changes in market conditions and T. Rowe Price's performance. The company's financials show strong market positioning with a notable revenue growth rate, exceptional net margin, ROE, and ROA, alongside a low debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

February 09, 2024 | 3:00 pm

MOH

Molina Healthcare (NYSE:MOH) received diverse analyst ratings over the last three months, with a recent positive shift in the average 12-month price target to $388.0, up 6.69% from $363.67. Analysts from Cantor Fitzgerald, UBS, and JP Morgan adjusted their ratings and price targets, reflecting changing market conditions and company performance. Molina Healthcare's financials show strong revenue growth, net margin, ROE, and ROA, but a higher debt-to-equity ratio compared to industry norms.

Portfolio Pulse from Benzinga Insights

February 09, 2024 | 3:00 pm